Bajaj HealthCare Limited (BOM:539872)
India · Delayed Price · Currency is INR 320.15
+2.65 (0.83%)
At close: Mar 6, 2026
Bajaj HealthCare Employees
Bajaj HealthCare had 918 employees as of March 31, 2025. The number of employees decreased by 131 or -12.49% compared to the previous year.
Employees
918
Change (1Y)
-131
Growth (1Y)
-12.49%
Revenue / Employee
6.67M INR
Profits / Employee
542.42K INR
Market Cap
10.11B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 918 | -131 | -12.49% |
| Mar 31, 2024 | 1,049 | -124 | -10.57% |
| Mar 31, 2023 | 1,173 | 121 | 11.50% |
| Mar 31, 2022 | 1,052 | 147 | 16.24% |
| Mar 31, 2021 | 905 | 190 | 26.57% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| IOL Chemicals and Pharmaceuticals | 2,891 |
| Shilpa Medicare | 998 |
| Sudeep Pharma | 740 |
| NGL Fine-Chem | 520 |
| Gujarat Themis Biosyn | 221 |
| Influx Healthtech | 163 |
| Shree Ganesh Remedies | 149 |
| Suven Life Sciences | 138 |
Bajaj HealthCare News
- 6 weeks ago - Bajaj Healthcare shares rise over 3% as Q3 revenue jumps 31.3% YoY to Rs 161.2 crore, net profit up 34.2% - Business Upturn
- 5 months ago - Bajaj Healthcare shares jump nearly 3% after CDSCO approval for Phase III trials of insomnia drug Suvorexant - Business Upturn
- 7 months ago - Why is Bajaj Healthcare stock falling despite 66% jump in Q1 profit? Explained - Business Upturn
- 11 months ago - Bajaj Healthcare shares rise nearly 3% as company acquires GenRx Pharmaceuticals to strengthen manufacturing footprint - Business Upturn
- 1 year ago - Bajaj Healthcare shares rise 5% in weak market as Q3 revenue jumps 13% YoY - Business Upturn
- 1 year ago - Corporate Earnings to Watch on February 11: Lupin, Vodafone Idea, Berger Paints, IRCTC, SAIL, and More - Business Upturn
- 1 year ago - Bajaj Healthcare secures DCGI approval to manufacture Pimavanserin in India - Business Upturn
- 1 year ago - Bajaj Healthcare shares surge 12% after securing exclusive rights for Magtein® in India - Business Upturn